Biotech Startups

Sofregen develops silk protein-based biomaterials and medical devices for soft tissue regeneration in aesthetic and surgical procedures. The company creates injectable and implantable products designed to support tissue repair and enhancement in cosmetic and reconstructive surgery.

1 investor

SoilWise develops biobased soil health technology, offering natural soil disinfection (Bodem Resetten), invasive plant control (Roots Reset), and algae and moss control (MossKade). The company provides these soil-borne solutions as alternatives to chemical treatments.

1 investor

Solarferm produces fermentation-grade sugar feedstock by combining carbon dioxide, hydrogen, engineered chemistry, and engineered microorganisms in a continuous thermocatalytic and electrochemical process that requires no crops or solid feedstocks. It supplies and licenses this "programmable sugar" technology to biomanufacturing customers across food, ingredients, materials, chemicals, fragrances, and pharmaceuticals.</parameter> <parameter name="founders">[]

1 investor

Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.

1 investor

SolasCure is developing mechanism-driven therapeutics to address biological barriers in chronic wound healing, with its lead candidate Aurase Wound Gel completing Phase II clinical trials. The company serves clinicians and healthcare systems seeking clinically validated approaches to improve outcomes for patients with non-healing or slowly healing wounds.

1 investor

An investment firm focused on healthcare and drug development, with a team stating over 30 years of combined experience in healthcare investments. It seeks to connect with companies aligned with advancing medicine.

1 investor

Solesis develops customizable applied biomaterial solutions using textiles, polymers, bioresorbables, and hybrids for innovators in the MedTech, life sciences, and pharma industries. It supports customers from development through commercialization of medical devices, single-use life science tools, and drug delivery systems.

1 investor

Soligenix is a biopharmaceutical company developing treatments for rare diseases, with programs in photodynamic therapy for cutaneous T-cell lymphoma and psoriasis, immunomodulatory drugs for inflammatory conditions, and vaccine candidates for infectious diseases. The company operates through two segments: Specialized BioTherapeutics, focused on advancing HyBryte and related therapies toward commercialization, and Public Health Solutions, which develops vaccines and therapeutics supported primarily by government contracts.

1 investor

Solvamed GmbH develops medical devices for the prevention and diagnosis of infections, with current research focused on preventing catheter sepsis (CutSep) and non-invasive sampling for respiratory infectious diseases. The company, a medical device manufacturer founded in 2013, is based in Rostock, Germany, and conducts research and development projects toward clinical approval studies.

1 investor

Solvd Health uses genetic data, machine learning, and custom algorithms to identify biological signals and develop clinical diagnostic solutions aimed at disease prevention. It builds data-driven products for patients and clinicians, two of which have received FDA Breakthrough Device designations.

1 investor

Solve Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADCs) and radiopharmaceuticals for solid tumors, using its CloakLink hydrophilic cleavable linker system and an integrated patient-selection diagnostic platform. The company has two lead programs in Phase 1 clinical development.

1 investor

QuartzBio provides a conversational AI platform that enables clinical-stage biopharma teams to gain real-time insights from fragmented sample, clinical, and biomarker data across their entire lifecycle. The platform uses domain-specific AI agents to transform data into actionable intelligence for pharmaceutical and biotechnology companies.

1 investor

SolvEat is a food-tech company that develops clinically validated bioactive botanical ingredient compositions, using microencapsulation to add functional health benefits to everyday foods like chocolate, snacks and beverages. It serves food and beverage manufacturers seeking to create wellness-oriented products that target specific health conditions.

1 investor

Solynta develops non-GMO hybrid breeding technology for potatoes, enabling faster variety development with enhanced disease resistance and climate adaptability. The company serves potato growers and food security initiatives across more than 40 countries, focusing on sustainable agricultural productivity.

1 investor

SOMAVERT is a prescription medicine (pegvisomant for injection) for treating acromegaly in patients whose disease has not been controlled by surgery or radiation or for whom those options are unsuitable. The site provides U.S. patient-focused information about the drug and its safe use.

1 investor

SonALAsense develops Sonodynamic Therapy (SDT), a non-invasive drug-device cancer treatment combining its SONALA-001 drug with an ultrasound device to treat deadly cancers such as High-Grade Gliomas and DIPG. The company is running Phase 0/1 and Phase 1/2 clinical trials and targets patients with brain tumors that typically require surgery.

1 investor

Sonas Pharma is a biotech startup developing endocannabinoid-based therapies, focused on engineering CB1R-targeted molecules to treat epilepsy and metabolic diseases such as obesity. Its drug development approach centers on receptor selectivity, peripheral restriction, and optimized pharmacological and safety properties beyond first-generation cannabinoid drugs like CBD.

1 investor

Biotherapeutics company taking the fight directly to cancer.

1 investor

Sophie's Bionutrients develops plant-based protein alternatives using microalgae and bioreactor technology for the food industry. The company creates sustainable, ocean-derived nutrients without animal farming for food manufacturers and consumers.

1 investor

1 investor

Soricimed is a private oncology-focused biopharma company developing targeted radioligand therapies and peptide-drug conjugates based on its proprietary TRPV6 peptide ligands. It seeks research collaborations and partnerships for its drug development platform.

1 investor

Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.

1 investor

Soterius provides drug safety, pharmacovigilance, and medical affairs services to pharmaceutical companies, including case intake and processing, signal detection, aggregate report writing, and compliance technology. It serves top pharma firms globally with safety experts, QPPVs, and Local Safety Managers across 60+ countries.

1 investor

Southern Star Research conducts clinical trials in reproductive and sexual health, partnering with sponsors to design and deliver Phase I and Phase II studies. The company focuses on patient-centered research across Australia and Asia-Pacific regions, with expertise in managing sensitive data, participant recruitment, and regulatory compliance in these therapeutic areas.

1 investor